Nvidia Moves Higher; Pfizer in Shutdown Flux; Rumble Rises
Nov 10, 2025
Nvidia shares are on the rise, bouncing back after a rough week, with insights into AI-driven supply and demand. Meanwhile, concerns loom as Pfizer navigates a potential government shutdown affecting healthcare subsidies, while also making a significant $86.25 billion bid for MetSara. The show also highlights Rumble's surge thanks to a new deal with a German data center operator, adjusting its terms amidst a tax probe. Tune in for a lively discussion on these market movers!
04:22
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Broad Market Rebound Eases Tech Panic
Markets rallied broadly with S&P futures and Nasdaq 100 contracts up as shutdown progress eased investor fears.
The Nasdaq had suffered its worst week since April, but tech rebounds led by Nvidia recovered part of last week's losses.
insights INSIGHT
Nvidia Leads Recovery On AI Demand
Nvidia led gains among the Magnificent Seven as markets rebounded on hopes the government shutdown will end.
CEO Jensen Huang pressed TSMC for more chip supply to meet booming AI demand, supporting the stock's recovery.
question_answer ANECDOTE
Huang's Taiwan Trip For More Chips
Jensen Huang made his third trip to Taiwan in three months to meet TSMC and request more chip supply.
He said he asked for extra chip capacity to keep up with booming AI demand.
Get the Snipd Podcast app to discover more snips from this episode
On this episode of Stock Movers: - Nvidia (NVDA) shares are moving higher in the premarket session with the company paring some of its losses from last week. S&P 500 futures rose 1% after a group of Senate Democrats broke with their party on a procedural measure to help Republicans advance a funding bill. Nasdaq 100 contracts gained 1.5% after the underlying index suffered its worst week since April. Nvidia Corp. led gains among the Magnificent Seven tech stocks in premarket trading, rising more than 3%. - Shares of Pfizer (PFE) edge higher in early trading, despite concerns as the US government shutdown approaches a resolution with no deal regarding healthcare subsidies. Meantime, Novo Nordisk's (NOVO) weekend decision to exit the bidding war for Metsera (MTSR) clears the way for Pfizer's amended offer of $86.25 per share -- or a total of up to $10 billion, which now requires formal Metsera shareholder approval at a November 13th meeting. The implied 10.1x EV-to-2030 consensus sales multiple is at the top end of recent Pharma-Biotech deals and highlights the continued significant interest of large-cap Pharma in clinical-stage obesity assets. - Shares of YouTube competitor Rumble (RUM) soared ahead of the US market open, after the conservative video service agreed to push ahead with a deal for German data center operator Northern Data AG at a reduced price, after news of a tax probe jeopardized the transaction. Northern Data owners will receive 2.0281 Rumble Class A shares per share they tender, it said in a statement Monday. That’s equivalent to about $11.95 per share, or €10.32, using Rumble’s Friday closing price. Bloomberg News reported Sunday that the companies, which are both backed by stablecoin issuer Tether Holdings Ltd., were nearing a deal.
Stock Movers